2019 AVBCC Summit Agenda

AVBCC

October 16-18, 2019

New York Athletic Club, New York, NY

Download the 2019 AVBCC Summit App!

Take a look at the exciting lineup for the 2019 Summit! Sessions feature experts and respected faculty from across the field. This is a must-attend event for all stakeholders in the cancer-care value equation. Book your spot today!

Place your cursor over a faculty member to learn more.

2019 Summit Agenda

 
  • Tuesday, October 15
    6:00pm – 8:00pm

    Professional Development Invitational Faculty Dinner

  • Wednesday, October 16
    7:45am – 9:00am

    Pre-Summit Professional Development Workshops – Registration

    9:00am – 10:15am

    Professional Workshop 1

    Working with Integrated Health Delivery Systems in Cancer Care Ecosystem

    Moderator: Barry Brooks, MD

    Faculty:

    • Myla Maloney, MBA, BCMAS
    • Chris Byrne
    • Tara Herington, RN
    • Niesha Griffith, RPh, MS, FASHP
    • John Sprandio, MD, FACP
    • Rob Hauser, PharmD, PhD
    • Marc Earl, PharmD, BCOP
    10:15am – 11:30am

    Professional Workshop 2

    Information Technologies, Artificial Intelligence, Pathways and Order Set, and Their Influence and Challenges in Cancer Care

    Data Information Needs for the Cancer Care Ecosystem Stakeholders

    Moderator: William McGivney, PhD

    Faculty:

    • David Waterhouse, MD, MPH
    • Marc Earl, PharmD, BCOP
    • Susan Weidner, MBA
    • Jeffrey Scott, MD
    • William Flood, MD
    • Andrew Hertler, MD, FACP
    • James Hamrick, MD, MPH
    • Aaron Lyss, MBA
    • Brian Bourbeau, MBA
    • Ira Klein, MD, MBA, FACP
    • John Sprandio, MD, FACP
    11:30am – 12:30pm

    Professional Workshop 3

    Topical Legal Issues in Cancer Care

    Big Data and Oncology Control of Data

    Updates from the Front Lines of PBM Battles

    Legal Considerations in Value Based Contracting

    Moderator: Jayson Slotnik, JD, MPH

    Faculty:

    • Daniel Frier, JD
    • Jonathon Levitt, JD
    • Lili Brillstein, MPH
    12:30pm – 1:30pm

    Luncheon and Panel Discussion

    Navigating Future Innovation and Legacy Challenges to the US Cancer Markets Ahead

    Moderator: William McGivney, PhD

    Faculty:

    • Aaron Lyss, MBA
    • Jeffrey Scott, MD
    • Gregory Simon, JD
    • Patricia Goldsmith
    • Ira Klein, MD, MBA, FACP
    1:30pm – 2:30pm

    Professional Workshop 4

    Pharmacy’s Emerging Influence and the Roles They Play Over Drug/Biologic Access and Impact on Cancer Care

    Moderator: Niesha Griffith, RPh, MS, FASHP

    Faculty:

    • Ali McBride, PharmD, MBA
    • Ray Bailey, BPharm, RPh
    • Steven D’Amato, RPh, BSPharm, BCOP
    • Michael Reff, RPh, MBA
    • Chris Byrne
    • Rob Hauser, PharmD, PhD
    • Kate Jeffers, PharmD, MHA, BCOP
    • Marc Earl, PharmD, BCOP
    2:30pm – 5:00pm

    Professional Workshop 5

    Value Positioning and Pricing for Cancer Drugs/Biologics and Technologies in the Real World and Perspectives in Cancer Care

    Value-Based Contracting: The Application, Mechanics, and Simulation in the Real World for Negotiating Value and Performance

    Moderator: Jeff Berkowitz, JD

    Faculty:

    • Larry Blandford, PharmD
    • Tesh Khullar, MBA
    • Ira Klein, MD, MBA, FACP
    • Charles Stevens, JD, MBA
    • Scott Kornhauser
    • Jeffrey Scott, MD
    • Rusty Massey
    5:00pm – 6:00pm

    Networking Reception

  • Thursday, October 17
    6:30am – 8:00am

    Summit Registration

    7:30am – 8:15am

    Session 1

    Real-World Noise, Trends, Realities, and Implications on the Road to Value-Based Contracting in Cancer Care

    Moderator: William McGivney, PhD

    Faculty:

    • Jeff Berkowitz, JD
    • Barry Brooks, MD
    • Jeffrey Scott, MD
    • Jeffrey Patton, MD
    • Tesh Khullar, MBA
    • Ira Klein, MD, MBA, FACP
    • John Doyle, PhD
    8:15am – 9:00am

    Keynote

    An Insider to Outsider’s Look at the Future of Cancer Care Delivery

    Speaker: Lee Newcomer, MD

    9:00am – 9:45am

    Session 2

    Washington and the Cancer Care Value Perspectives

    Moderator: Jayson Slotnik, JD, MPH

    Faculty:

    • Blair Childs
    • Gregory Simon, JD
    • Brad Tallamy
    • Ben Jones
    • Barrett Thornhill, JD
    9:45am – 10:30am

    Session 3

    Employers and the Cancer Care Value Perspectives

    Moderator: Arthur Taft, MBA

    Faculty:

    • Michelle Martin
    • Michael Thompson
    • Eslyn Byarm, RN, BSN, CCM, AATMC
    • F. Randy Vogenberg, PhD
    10:30am – 11:15am

    Session 4

    Insurance Payers and the Cancer Care Value Perspectives

    Moderator: Mike Kolodziej, MD

    Faculty:

    • Surya Singh, MD
    • William Winkenwerder, Jr, MD
    • Scott Breidbart, MD
    • Kent Rogers, MBA
    • Steven Peskin, MD
    • Bryan Loy, MD, MBA
    • Bob McDonough, MD
    11:15am – 12:00pm

    Session 5

    Community Cancer Care and the Value Perspective

    Moderator: Barry Brooks, MD

    Faculty:

    • Aaron Lyss, MBA
    • David Waterhouse, MD, MPH
    • Nicolas Ferreyros
    • Russell Gollard, MD
    • Jeffrey Scott, MD
    • Lee Schwartzberg, MD, FACP
    • Bryan Loy, MD, MBA
    12:00pm – 12:45pm

    Session 6

    Cancer Centers and the Integrated Health Delivery Systems and the Cancer Care Value Perspectives

    Moderator: William McGivney, PhD

    Faculty:

    • Christian Downs, MHA, JD
    • Pat Basu, MD, MBA
    • Myla Maloney, MBA, BCMAS
    • Al Benson III, MD, FACP, FASCO
    • Niesha Griffith, RPh, MS, FASHP
    • Marc Earl, PharmD, BCOP
    1:15pm – 2:00pm

    Session 7

    Biotech and Pharmaceutical Developers’ Perspectives on the Value Innovation Is Delivering to Stakeholders in Cancer Care

    Moderator: William McGivney, PhD

    Faculty:

    • Michael Valenta
    • Alex Santini
    • Eric Dozier
    • Mitch Higashi
    • Don Sawyer
    2:00pm – 2:45pm

    Keynote

    Opinions and Thoughts on the Future of Cancer Care in America

    Speaker: Scott Gottlieb, MD

    2:45pm – 3:45pm

    Key Opinion Leader Session 1

    From Innovation to Commercialization: Are Manufacturers and Other Key Cancer Therapy Development Stakeholders Evolving Rapidly Enough to Meet the Clinical and Commercial Demands for New, More Efficacious Therapies?

    Moderator: Morrie Ruffin

    Faculty:

    • Brian Leyland-Jones, BSc, MBBS, PhD, FRACP, FRCPC
    • Gregory MacMichael, PhD
    • Kimberly Noonan
    • Kristi Jones
    • Amy DuRoss
    • Michele Korfin

    Key Opinion Leader Session 2

    Liquid Biopsy: Clinical–Economic Considerations for Value-Based Healthcare

    Moderator: Stan Skrzypczak, MS, MBA

    Faculty:

    • Bob Li, MD, MPH
    • Lee Schwartzberg, MD, FACP
    • Rick Lanman, MD
    • Mark Hiatt, MD
    • Bob McDonough, MD

    Key Opinion Leader Session 3

    Establishing Cancer Care Coordination Processes and Standardization for Oncology Nurse Navigators

    Moderator: Sharon Gentry, MSN, RN, AOCN, CBCN, HON-ONN-CG

    Faculty:

    • Mary Rivera, RN, AOCNS
    • Anne Ireland, MSN, RN, AOCN
    • Janet Gordils-Perez, DNP, RN, ANP-BC, AOCNP
    • Emily Gentry, RN, BSN, OCN

    Key Opinion Leader Session 4

    Emerging Data Opportunities for Enhancing the Value of Oncology Therapeutics

    Moderator: Darin Rubin

    Faculty:

    • Ira Klein, MD, MBA, FACP
    • Joe Baffone
    • Ash Malik, MBA
    • Danielle Ziernicki, PharmD
    • Staurt Genschaw
    • Robert Miller, MD, FACP, FASCO
    3:45pm – 4:45pm

    Key Opinion Leader Session 5

    Genomics and Personalized Medicine Innovation Value

    Moderator: Stan Skrzypczak, MS, MBA

    Faculty:

    • Lee Schwartzberg, MD, FACP
    • Rachel Anhorn, PharmD
    • John Simmons, PhD
    • Edward Abrahams, PhD
    • Gary Palmer, MD, JD, MBA, MPH
    • Rick Lanman, MD
    • James Almas, MD
    • Ted Snelgrove, MBA

    Key Opinion Leader Session 6

    Oncology Drug Supply Chain Channels and the Move to Value

    Moderator: Bob Charles, MBA

    Faculty:

    • Niesha Griffith, RPh, MS, FASHP
    • Scott Jauch
    • Mike McCarthy
    • Amy Valley, PharmD, BCOP
    • Matt Outten, MBA, ALM, CPC
    • Mark Hagler
    • Pete Perron
    • Cynthia Radford
    • Marc Earl, PharmD, BCOP

    Key Opinion Leader Session 7

    Legal Headwind and Tailwind Impacting Cancer Patients, Providers, Payers, and Pharma

    Moderator: Alexis Bortniker, JD

    Faculty:

    • Jennifer Walsh
    • Adria Warren, JD

    Key Opinion Leader Session 8

    Payers and Value-Based Care Pilots and Innovation Use Cases in Cancer Care

    Moderator: Pamela Pelizzari, MPH

    Faculty:

    • Bo Gamble
    • Christian Downs, MHA, JD
    • Dan Renick, RPh
    • John Sprandio, MD, FACP
    • Bob McDonough, MD
    • Bryan Loy, MD, MBA
    4:45pm – 5:45pm

    Key Opinion Leader Session 9

    Value-Based Contracting Case Studies and What Failed, Worked, and Learned

    Moderator: Jeff Berkowitz, JD

    Faculty:

    • Bethanie Stein, PharmD
    • Kent Rogers, MBA
    • Ross Maclean, MD
    • Scott Jauch
    • Jim Clement

    Key Opinion Leader Session 10

    Patient Centricity and Digital Platforms: Cancer Survival Outside of Medicine’s 4 Walls

    Moderator: Rick Lee, MBA, PhD

    Faculty:

    • Jeremy Nobel, MD, MPH
    • Charlie Coltman
    • Harry Travis, BS Pharm, MBA

    Key Opinion Leader Session 11

    Biosimilars and Follow-on Technology Value Creation

    Moderator: Sean McGowan, MBA

    Faculty:

    • William Yoon, MD
    • Rob Stianchi
    • Chrys Kokino, MBA
    • Neal Lambert

    Key Opinion Leader Session 12

    The Role of ICER as a US-HTA with Payer & Manufacturer and Views on the Level of Influence They Have on Markets

    Moderator: Charles Stevens, JD, MBA

    Faculty:

    • Kathryn Lang, MD
    • Kelly Franchetti, RN, CCRN, CEN
    • Jenny Lee, PharmD, MBA, MPH
    5:45pm – 6:30pm

    Session 8

    Key Cancer Researchers and Their Own Development Perspectives and Experiences

    Moderator: Neil Canavan

    Faculty:

    • Rob Hauser, PharmD, PhD
    • Ryan Berube
    • Mimi Schnier
    • Luis Diaz, MD
    • Cliff Hudis, MD
    • Joshua Brody, MD
    6:30pm – 8:30pm

    SAA Reception/Auction

  • Friday, October 18
    6:30am – 7:30am

    Summit Registration

    7:00am – 7:45am

    Session 9

    Comprehensive Near-Term Oncology Pipeline Overview Covering Oral-Infused-Gene Therapies

    Moderator: Jeffrey Bockman, PhD

    Faculty:

    • Cheryl Allen, PharmD, MBA
    • Michael Mong, PharmD
    7:45am – 8:30am

    Key Opinion Leader Session 13

    Pharma and the Opportunities Ahead for New Innovative Value-Based Contracting Methodologies

    Moderator: Roger Longman

    Faculty:

    • Ira Klein, MD, MBA, FACP
    • John Doyle, PhD
    • Scott Jauch
    • Rena Goins
    • Joe Vandigo, MBA, PhD
    • Gerry Gleeson, MBA

    Key Opinion Leader Session 14

    Innovation to Improve Prevention and Diagnosis, and Provide Patient-Centered Value-Based Cancer Care

    Moderator:

    Faculty:

    • Cardinale Smith, MD, PhD
    • Kathryn Lang, MD
    • John Sprandio, MD, FACP
    • Gena Cook
    • Judith Gallagher, MBA, PA-C
    • Anil Rustgi, MD
    • Christina Ritter, PhD

    Key Opinion Leader Session 15

    Value of Tele-Health and Digital Technologies in Cancer Care

    Moderator: Steven Peskin, MD

    Faculty:

    • Harry Travis, BS Pharm, MBA
    • Bob Gold
    • Pierre Leurent
    8:30am – 9:15am

    Keynote

    Projecting on the Look Ahead as Public Policy and Market Reality Converge

    Speaker: John O’Brien, PharmD, MPH

    9:15am – 10:15am

    Session 10

    Value Equations and Real-World Applications in Cancer Care

    Moderator: William McGivney, PhD

    Faculty:

    • Peter Bach, MD
    • Kent Rogers, MBA
    • Surya Singh, MD
    • Larry Blandford, PharmD
    • Kathryn Lang, MD
    • John O’Brien, PharmD, MPH
    10:15am – 11:00am

    Key Opinion Leader Session 16

    Pharmacy Benefit Managers and the Future Role Managing of Cancer Drug Optimization and Value

    Moderator: Barry Brooks, MD

    Faculty:

    • Gina Guinasso, JD
    • Mostafa Kamal
    • Benito Fernandez
    • Ross Hoffman, MD
    • Mike Einodshofer, RPh, MBA
    • Surya Singh, MD

    Key Opinion Leader Session 17

    Practice Transformation Embracing Clinical Decision Support Systems and Care Management Processes and Influence on Value-Based Cancer Care

    Moderator: Mike Kolodziej, MD

    Faculty:

    • Andrew Norden, MD, MPH, MBA
    • James Hamrick, MD, MPH
    • Lee Schwartzberg, MD, FACP
    • Lalan Wilfong, MD
    • Susan Weidner, MBA

    Key Opinion Leader Session 18

    Cancer Care Behavior Management Program to Increase Human Resiliency to Stay on Therapy and Achieve Quality Measures While Reducing Clinical Fatigue

    Moderator: Bob Gold

    Faculty:

    • Steven Peskin, MD
    • Sarah Beadling
    • Deborah Toppmeyer, MD
    • Judith Haber, PhD, APRN, BC, FAAN
    11:00am – 12:15pm

    Key Opinion Leader Session 19

    Global Oncology Trends Reports, Therapeutics, Clinical Development, and Health System Implications

    Moderator: Burt Zweigenhaft, BS

    Faculty:

    • Douglas Long, MBA
    • Michael Kleinrock

    Key Opinion Leader Session 20

    Value-Based Contracting in Cancer Care and the Challenges to Coding, Pricing, and Reimbursement

    Moderator: Denise Pierce

    Faculty:

    • Brian Gockerman
    • Gail Airasian, MBA
    • John Sprandio, MD, FACP
    • Ash Malik, MBA
    • Ron DiGiaimo, MBA

    Key Opinion Leader Session 21

    Oncology Nurses and Navigators and Their Expanded Role in the Value Equation

    Moderator: Andrea Dwyer

    Faculty:

    • Brenda Nevidjon, MSN, RN, FAAN
    • Danelle Johnston, MSN, RN, HON-ONN-CG, OCN
    • JoAnn Lovins, MS, RN
    • Monica Dean
    • Kendra Barber, MHA, RN, OCN
    12:15pm – 1:00pm

    Key Opinion Leader Session 22

    Capital Markets Views on Value Cancer Care

    Moderator: Dennis Purcell, MBA

    Faculty:

    • Lisa Gill
    • Robert Jones
    • Jonathon Fassberg
    • Dara Lundon

    Key Opinion Leader Session 23

    Oncology Pharmacy and Emerging Role in Integrative Cancer Care

    Moderator: Niesha Griffith, RPh, MS, FASHP

    Faculty:

    • Ali McBride, PharmD, MBA
    • Ray Bailey, BPharm, RPh
    • Steven D’Amato, RPh, BSPharm, BCOP
    • Ray Muller, MS, RPh, FASHP
    • Rob Hauser, PharmD, PhD
    • Stacey McCullough, PharmD

    Key Opinion Leader Session 24

    Data Information Needs and Requirements for Future Cancer Care

    Moderator:

    Faculty:

    • Marc Earl, PharmD, BCOP
    • Ash Malik, MBA
    • Joel Brill, MD, FACP, AGAF, FASGE, FACG
    • Lalan Wilfong, MD
    • Brian Bourbeau, MBA
    1:15pm – 2:00pm

    Key Opinion Leader Session 25

    New Access Challenges Facing Cancer Patients and the Future Missions and Initiatives of Advocacy Groups to Ensure Access to Cancer Care

    Moderator: Gregory Simon, JD

    Faculty:

    • Gena Cook
    • Patricia Goldsmith
    • Clorinda Walley
    • Rose Gerber
    • Deborah Kamin, RN, PhD

    Key Opinion Leader Session 26

    Oncology Drug Pricing Under Extreme Market Pressures and the Projected Impact on All Stakeholder Channels in the Future

    Moderator: Gabriela Dieguez, FSA, MAAA

    Faculty:

    • John O’Brien, PharmD, MPH
    • David Wierz
    • Brian Agnew

    Key Opinion Leader Session 27

    Legal Considerations for Oncology Manufacturers Structuring Value-Based Models

    Moderator:

    Faculty:

    • John Morrone, JD
    • Jesse Dresser, JD
    2:00pm – 2:45pm

    Key Opinion Leader Session 28

    Cancer Care: The Real-World Economics and Value Realities

    Moderator: Jayson Slotnik, JD, MPH

    Faculty:

    • Brian DeBusk, PhD, MBA
    • Kathryn Lang, MD
    • Bruce Pyenson, FSA, MAAA

    Key Opinion Leader Session 29

    Artificial Intelligence in Oncology Value-Based Care

    Moderator: John Frownfelter, MD, FACP

    Faculty:

    • Amy Ellis
    • Ray Page, DO, PhD, FACOI, FASCO
    • Annastasiah Mhaka, PhD
    • Sibel Blau, MD
    • Eric Schultz

    Key Opinion Leader Session 30

    Palliative Care and the Value Derived in Cancer Care

    Moderator: Thomas LeBlanc, MD

    Faculty:

    • Gena Cook
    • Sarah Beadling
    • Torrie Fields, MPH
    2:45pm – 3:30pm

    Session 11

    Cancer Care Future State and Predictions

    Moderator: William McGivney, PhD

    Faculty:

    • Cliff Hudis, MD
    • Lee Newcomer, MD
    • Jeffrey Patton, MD
    • Mike Kolodziej, MD
    • Barry Brooks, MD
    3:30pm – 4:15pm

    Closing Reception

*Agenda subject to change.

Return to Top